Healthcare Realty Trust Inc
For the period ended Sep 30, 2025. Filed Oct 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 31, 2025
HR$19.20+0.7%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Balance Sheets
| ASSETS | ||
|---|---|---|
| UnauditedSEPTEMBER 30, 2025 | DECEMBER 31, 2024 | |
| Real estate properties | ||
| Land | $1,066,616 | $1,143,468 |
| Buildings and improvements | 8,557,270 | 9,707,066 |
| Lease intangibles | 504,309 | 664,867 |
| Personal property | 6,854 | 9,909 |
| Investment in financing receivable, net | 123,346 | 123,671 |
| Financing lease right-of-use assets | 75,462 | 77,343 |
| Construction in progress | — | 31,978 |
| Land held for development | 57,203 | 52,408 |
| Total real estate properties | 10,391,060 | 11,810,710 |
| Less accumulated depreciation and amortization | (2,381,297) | (2,483,656) |
| Total real estate properties, net | 8,009,763 | 9,327,054 |
| Cash and cash equivalents | 43,345 | 68,916 |
| Assets held for sale, net | 604,747 | 12,897 |
| Operating lease right-of-use assets | 209,291 | 261,438 |
| Investments in unconsolidated joint ventures | 458,627 | 473,122 |
| Other assets, net | 533,874 | 507,496 |
| Total assets | $9,859,647 | $10,650,923 |
| LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, AND STOCKHOLDERS' EQUITY | ||
| Liabilities | ||
| Notes and bonds payable | $4,485,706 | $4,662,771 |
| Accounts payable and accrued liabilities | 173,784 | 222,510 |
| Liabilities of assets held for sale | 69,808 | 1,283 |
| Operating lease liabilities | 166,231 | 224,499 |
| Financing lease liabilities | 72,654 | 72,346 |
| Other liabilities | 146,618 | 161,640 |
| Total liabilities | 5,114,801 | 5,345,049 |
| Commitments and contingencies | ||
| Redeemable non-controlling interests | 4,332 | 4,778 |
| Stockholders' equity | ||
| Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding | — | — |
| Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 351,604 and 350,532 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 3,516 | 3,505 |
| Additional paid-in capital | 9,134,486 | 9,118,229 |
| Accumulated other comprehensive loss | (6,461) | (1,168) |
| Cumulative net income attributable to common stockholders | 113,847 | 374,309 |
| Cumulative dividends | (4,562,454) | (4,260,014) |
| Total stockholders' equity | 4,682,934 | 5,234,861 |
| Non-controlling interest | 57,580 | 66,235 |
| Total equity | 4,740,514 | 5,301,096 |
| Total liabilities, redeemable non-controlling interests, and stockholders' equity | $9,859,647 | $10,650,923 |
The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.